IBB Stock UPDATES Nasdaq Biotechnology Ishares (IBB) 290.63 10/29/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Nasdaq Biotechnology Ishares (IBB) 290.63 $IBB

Watch for iShares Nasdaq Biotechnology Index to Potentially Pullback After Gaining 1.21% Yesterday
Comtex SmarTrend(R) - Tue Oct 28, 4:27PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $291.52 to a high of $294.65. Yesterday, the shares gained 1.2%, which took the trading range above the 3-day high of $290.44 on volume of 1.6 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
IBB: 290.63 (-3.32)

SmarTrend Watching for Potential Pullback in Shares of iShares Nasdaq Biotechnology Index After 1.21% Gain
Comtex SmarTrend(R) - Tue Oct 28, 4:27PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $291.52 to a high of $294.65. Yesterday, the shares gained 1.2%, which took the trading range above the 3-day high of $290.44 on volume of 1.6 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
IBB: 290.63 (-3.32)

After Yesterday's Rally of 2.66% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Thu Oct 23, 4:13PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $277.90 to a high of $285.23. Yesterday, the shares gained 2.7%, which took the trading range above the 3-day high of $278.81 on volume of 1.9 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
IBB: 290.63 (-3.32)

SmarTrend Watching for Potential Pullback in Shares of iShares Nasdaq Biotechnology Index After 2.66% Gain
Comtex SmarTrend(R) - Thu Oct 23, 4:12PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $277.90 to a high of $285.23. Yesterday, the shares gained 2.7%, which took the trading range above the 3-day high of $278.81 on volume of 1.9 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
IBB: 290.63 (-3.32)

Are Blue-Chip Stocks Past Their Prime or Still Worth Owning?
at The Street - Thu Oct 23, 3:15PM CDT
The 'Fast Money' trading panel looks at which blue-chip stocks investors should own, as well as at the overall stock market.
MMM: 151.01 (-0.05), GE: 25.66 (-0.22), HON: 95.05 (-0.12), NKE: 91.95 (-0.50), PRU: 86.70 (-0.09), UTX: 105.85 (-0.42), XBI: 169.62 (-1.89), SKX: 54.15 (+0.07), IBB: 290.63 (-3.32), KKR: 22.25 (-0.37), INTC: 33.92 (+0.18), UPS: 102.62 (-0.28), SPY: 198.11 (-0.30), IBM: 163.46 (-0.14), DIA: 169.40 (-0.26), DAN: 19.72 (-0.30), CAT: 100.19 (-0.97), MSFT: 46.62 (+0.13), KO: 40.96 (+0.40), IR: 61.48 (-0.52), DIS: 89.53 (-0.40), CLF: 10.22 (-1.07), WLT: 2.34 (-0.02), UA: 64.27 (-0.03), FTNT: 25.74 (-0.01)

3 Stocks I'll Buy if the Market Crashes
George Budwell, The Motley Fool - Motley Fool - Mon Oct 20, 12:01PM CDT
After a monstrous bull run of late, the stock market finally started to pullback. The Nasdaq Biotechnology Index , for instance, fell by nearly 7% last week alone: Even so, it's important to keep the magnitude of this week's drop in...
ACAD: 27.63 (-0.26), GILD: 110.72 (-2.73), SHPG: 196.45 (-1.35), NPSP: 27.21 (-0.91), IBB: 290.63 (-3.32), ABBV: 59.98 (-0.95)

Look for Shares of iShares Nasdaq Biotechnology Index to Potentially Pullback after Yesterday's 1.68% Rise
Comtex SmarTrend(R) - Fri Oct 17, 4:13PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $263.11 to a high of $268.03. Yesterday, the shares gained 1.7%, which took the trading range above the 3-day high of $264.14 on volume of 1.7 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
IBB: 290.63 (-3.32)

IBB, GULF, GDP, DBOEY, Added To Naked Short Lists Today
M2 - Mon Oct 13, 10:51AM CDT
BUYINS.NET, www.buyins.net , announced today that these select companies have been Added To the NASDAQ, AMEX, NYSE, OTCBB and Pinksheet naked short threshold lists. Ishares Nasdaq Biotechnology (NASDAQ:IBB), WisdomTree Middle East Dividend Fund (NASDAQ:GULF), Goodrich Petroleum Corp (NYSE:GDP), Deutsche Boerse AG (OTC BOEY). For a complete list of companies on the naked short lists please visit our web site. To find the SqueezeTrigger Price before a short squeeze starts in any stock, go to http://www.buyins.net .
GDP: 8.70 (+0.03), GULF: 23.21 (+0.12), IBB: 290.63 (-3.32)

iShares Nasdaq Biotechnology Index Set to Possibly Rebound After Yesterday's Selloff of 2.09%
Comtex SmarTrend(R) - Fri Oct 10, 4:47PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $262.08 to a high of $271.25. Yesterday, the shares fell 2.1%, which took the trading range below the 3-day low of $264.52 on volume of 1.9 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
IBB: 290.63 (-3.32)

After Yesterday's Decline of 2.09%, iShares Nasdaq Biotechnology Index Offers Investors Better Value
Comtex SmarTrend(R) - Fri Oct 10, 4:47PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $262.08 to a high of $271.25. Yesterday, the shares fell 2.1%, which took the trading range below the 3-day low of $264.52 on volume of 1.9 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
IBB: 290.63 (-3.32)

'Fast Money' Recap: Relief About the Stock Market Rally
at The Street - Thu Oct 09, 4:00AM CDT
The trading panel discussed where they are putting their money after the change in market direction.
F: 13.91 (-0.25), LMT: 186.43 (+0.88), ARWR: 6.70 (-0.17), XOP: 60.07 (+0.66), XBI: 169.62 (-1.89), C: 52.65 (+0.21), M: 57.45 (+0.18), IBB: 290.63 (-3.32), SHLD: 36.99 (-0.43), AA: 16.27 (-0.33), TJX: 62.72 (+0.02), RIG: 29.90 (+0.01), GILD: 110.72 (-2.73), GLD: 116.41 (-1.69), TGT: 60.89 (+0.24), JCP: 7.59 (+0.16), GM: 30.72 (-0.45), GOOGL: 558.45 (-0.49), GPS: 37.56 (+0.28), TWTR: 42.08 (-1.70), XLE: 85.99 (+0.28)

'Fast Money' Recap: What Should You Buy in a Declining Market?
at The Street - Wed Oct 08, 4:00AM CDT
The trading panel discusses Yum! Brands, the mining industry and Ebola treatments.
PEI: 21.10 (+0.07), CLR: 56.53 (+0.11), GMCR: 147.87 (+1.21), TKMR: 16.87 (-1.46), IBB: 290.63 (-3.32), M: 57.45 (+0.18), JBLU: 11.54 (+0.16), UPS: 102.62 (-0.28), PEP: 94.69 (-0.57), SBUX: 76.54 (-0.51), AGN: 186.77 (+4.17), SAVE: 71.54 (+0.48), CMRX: 29.79 (-1.65), EOG: 93.13 (+1.63), DPZ: 88.98 (-0.02), COST: 131.93 (+0.87), GOOGL: 558.45 (-0.49), CMLS: 3.77 (-0.11), AAPL: 107.34 (+0.60), MBLY: 50.90 (-0.19), YUM: 69.61 (-0.60), APC: 91.32 (+0.97), AMBA: 42.35 (+0.91), AEC: 19.20 (-0.15), GPRO: 67.89 (-1.41), ETN: 65.92 (+1.14), IR: 61.48 (-0.52), GSK: 45.08 (-0.02), PXD: 186.10 (+2.34), MCD: 92.73 (+0.13), GM: 30.72 (-0.45), IWM: 113.90 (-0.27), SODA: 21.44 (-0.48)

Why Is George Soros Buying Celgene Corporation?
George Budwell, The Motley Fool - Motley Fool - Mon Oct 06, 9:01AM CDT
Superinvestors have transcended the investing landscape for one simple reason: they are awfully good at making money. Many smaller investors therefore like to track the movements of these "elephants" to see what they are buying and selling in hopes...
IBB: 290.63 (-3.32), CELG: 105.14 (-0.56)

The Complete Guide to Biotech ETFs - ETF News And Commentary
Zacks Equity Research - Zacks Investment Research - Thu Oct 02, 11:09AM CDT
Biotech sector appears to be back on track with fundamentals remaining attractive.
PBE: 49.36 (-0.23), FBT: 97.68 (-0.61), XBI: 169.62 (-1.89), BBH: 113.38 (-1.17), IBB: 290.63 (-3.32)

SmarTrend Watching for Potential Rebound in Shares of iShares Nasdaq Biotechnology Index After 1.50% Loss
Comtex SmarTrend(R) - Wed Oct 01, 4:11PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $267.58 to a high of $273.65. Yesterday, the shares fell 1.5%, which took the trading range below the 3-day low of $272.22 on volume of 2.0 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
IBB: 290.63 (-3.32)

'Fast Money' Recap: How to Trade After the Market's Drop
at The Street - Fri Sep 26, 4:00AM CDT
The trading panel likes the idea of buying Microsoft, Intel and other tech stocks if the market opens lower Friday
BIIB: 315.06 (-2.97), NKE: 91.95 (-0.50), XBI: 169.62 (-1.89), BBRY: 10.51 (-0.14), IBB: 290.63 (-3.32), INTC: 33.92 (+0.18), YHOO: 45.43 (-0.44), DD: 66.80 (-1.15), GOOGL: 558.45 (-0.49), MSFT: 46.62 (+0.13), AAPL: 107.34 (+0.60), REGN: 387.70 (-10.19), AMZN: 294.12 (-1.47), MU: 32.28 (-0.33), VRTX: 109.91 (-4.16), EMN: 74.52 (-2.03), FB: 75.86 (-4.91), BRCM: 40.33 (-0.09), PFE: 29.49 (+0.40), AMGN: 158.88 (+1.69), TIF: 94.76 (+0.02), HPQ: 35.38 (-0.16), PCLN: 1,144.22 (-12.40), LULU: 41.18 (-0.55), MHR: 4.71 (+0.09), GILD: 110.72 (-2.73), FNV: 50.77 (-1.74), RGLD: 62.98 (-3.19), IWM: 113.90 (-0.27), DOW: 47.38 (-0.60), BABA: 98.31 (-1.37), AN: 55.76 (+0.18)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Trimble's AI Tool Tackles Chronically Delayed Projects

Updated Category News Views 108

Facing Down Delays with Trimble's New AI Tool In an industry where timelines are often more of a suggestion than a rule, Trimble's dropping a new hammer with its Connect Scheduling solution. This isn't your garden-variety update; it's a full-fledged assault on the inefficiencies plaguing construction scheduling today. With Trimble Connect Scheduling, folks on the ground...

Continue Reading
PrimeFlight Welcomes CEO Amath Fall for Global Growth

Updated Category News Views 88

A New Era Begins at PrimeFlight On a cloudy November morning in Sugar Land, Texas, some interesting news broke out of PrimeFlight Aviation Services. They've made what seems like a pivotal move by appointing Amath Fall as their new Chief Executive Officer, effective immediately. As PrimeFlight continues to elbow its way into new market territory, having someone like Fall...

Continue Reading
LG Wins CES Honor with Breakthrough Battery Diagnostic Tech

Updated Category News Views 204

Speeding Up Diagnostics: A Major Leap Forward In a world where every second counts, LG Energy Solution strikes gold with their latest innovation, Re.Pulse. CES Innovation Awards 2027 has honored LG for this slick piece of tech that trims down battery diagnosis time from a snail's pace seven hours to a lightning-fast 10 minutes. It's not just about speed—it’s also...

Continue Reading
Tom Hanks' New Campaign Boosts Veterans' Morale

Updated Category News Views 57

Coffee and Kindness: Tom Hanks' Salute to Veterans Alright, let's dive right into the steaming pot that is Tom Hanks' latest venture, shall we? The man who’s charmed us on screen is stirring up another kind of magic off it. Hanks For Our Troops, his coffee company, is launching a campaign aptly named "(T)HANKS"—a nationwide blitz to honor and empower our veterans this...

Continue Reading
Ebix Relaunches A.D.A.M. SmartCare Platform for Clinicians

Updated Category News Views 20

Revolutionizing Patient Education with SmartCare When you're in the thick of things, juggling a half-dozen patients with different needs all in a day’s work, you want your tools to be as fast and straightforward as a greasy spoon diner breakfast—simple, satisfying, and utterly dependable. And Ebix is betting they've cooked up just the recipe for that with their...

Continue Reading
Millrose Faces Class Action Over Misleading Investors

Updated Category News Views 46

Millrose Properties Steps Into Legal Hot Water Ah, stocks and legal squabbles—a pairing as old as Wall Street itself. Now, folks, it seems Millrose Properties, Inc. has stepped right onto the chopping block with a lawsuit knocking on their door over claims they misled investors. The suits from the DJS Law Group aren't mince words: we're talking alleged violations of the...

Continue Reading
Human Development Fund's Bold Partnership for Growth

Updated Category News Views 131

An Unusual Alliance with Far-Reaching Implications Every once in a while, a nonprofit steps up with a move that makes even the toughest investors take notice. This isn't some Wall Street ticker talk, sure, but it’s worth turning your chair toward the table. The Human Development Fund (HDF) has penned a strategic deal with the Islamic Development Bank (IsDB), putting its...

Continue Reading
Orthodontic Treatment: Timelines and Expert Insights

Updated Category News Views 87

Getting Straight to the Point: Orthodontic Timelines Remember that time your teen self thought braces would be over in a flash? Yeah, well, Dr. Judith Okun might have a few words on that. When it comes to braces, you better buckle up for the long haul. Most folks are looking at a solid two years, give or take. No magic shortcuts here, just solid orthodontic science. The...

Continue Reading
Veterans Hit Sales Milestones in Nexion Travel Program

Updated Category News Views 43

Veterans Carve New Paths in Travel Entrepreneurship Nexion Travel Group is giving veterans and military spouses a different kind of battleground—one where the prize isn't a medal, but a successful travel business. With their Veterans in Travel program, they've hit milestones that deserve more than just a polite nod. Surpassing Last Year's Benchmarks Let's cut to the...

Continue Reading
ResMed Faces Probe: Potential Breach Alert for Investors

Updated Category News Views 81

Cracks Surfacing at ResMed? Alright, folks, ResMed Inc. (NYSE: RMD) is facing a bit of heat these days. We're talking about a shareholder alert as Levi & Korsinsky, noted legal hounds when it comes to financial misconduct, have decided to dig deep into ResMed. They're looking to uncover any possible breaches of fiduciary duties by some of the top brass at this sleep apnea...

Continue Reading

Top 5 Most Recently Viewed Articles

KOCCA's U-KNOCK 2025: A New Era for Global Content

Updated Category News Views 309

About U-KNOCK 2025 U-KNOCK 2025 is a prominent event designed to bring together Korea’s leading creative content companies with global investors. This initiative is backed by the Ministry of Culture, Sports and Tourism of the Republic of Korea and organized by the Korea Creative Content Agency (KOCCA). It celebrates the growing influence of Korean media and aims to...

Continue Reading
DICK'S Sporting Goods Achieves Impressive Growth in Q1 2025

Updated Category News Views 482

DICK'S Sporting Goods Reports Preliminary Q1 2025 Results DICK'S Sporting Goods, Inc. (NYSE: DKS), a prominent U.S. full-line omni-channel sporting goods retailer, has recently shared its preliminary financial results for the first quarter of 2025. This exciting announcement highlights their robust growth and performance. Strong Sales Growth and Earnings The initial...

Continue Reading
Empowering Farmers: The Significance of Farm Transition Appreciation Day

Updated Category News Views 230

Farm Transition Appreciation Day: A Growing Initiative Farm Management Canada is spearheading an exciting event known as Farm Transition Appreciation Day (FTADay). This initiative has gained remarkable traction, becoming a celebrated occasion aimed at recognizing the efforts and planning needed for ensuring the future sustainability of farming here in Canada. The Future...

Continue Reading
Innovative Power Solutions: Flex Power and Renesas Collaboration

Updated Category News Views 217

Flex Power Modules and Renesas Join Forces Flex Power Modules is excited to announce a strategic partnership with Renesas aimed at transforming power management solutions. This collaboration focuses on next-generation power systems tailored for CPUs, GPUs, FPGAs, ASICs, and accelerator cards, all essential for efficiently supporting AI operations. Vertical Power Delivery...

Continue Reading
Shareholding Update Reveals Key Developments at IDEX Biometrics

Updated Category News Views 134

Significant Developments in Shareholding at IDEX Biometrics ASA IDEX Biometrics ASA recently disclosed important information regarding its shareholding structure. The announcement was made on behalf of one of its shareholders, reflecting the company's ongoing commitment to transparency. Extraordinary General Meeting Insights The announcement references a significant...

Continue Reading